Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Tuesday, May 19, 2026

Snapshot: May 19, 2026 · 6:00 PM 100 stocks analyzed

Down Day

Tue, May 19, 2026 Broad Selloff High

Broad selloff hit all three major indices with Russell 2000 down 1.01%, while extreme dispersion saw mega-movers like INM (+135% on merger news) and JYD (-65.9% with no catalyst…

65% Broad market selloff with Russell 2000 leading downside: S&P 500 fell 0.65%, NASDAQ dropped 0.84%, and small caps declined 1.01%, signaling coordinated risk-off across all three indices even as VIX edged up only 1.35%, suggesting fear remained measured despite the selloff's breadth.
25% Extreme single-stock dispersion with headline-driven movers: INM rocketed 135% on a merger announcement with Mentari Therapeutics, while NXXT doubled on record revenue growth and AMST surged 120% on a major healthcare AI customer win, contrasting sharply with unexplained craters like JYD's 65.9% plunge and BTM's 28% bankruptcy collapse.
10% Healthcare sector concentration dominance: healthcare accounted for 32% of gainers and 26% of losers, with WOK extending a painful 5-day losers streak and five debutants (INM, AMST, CNEY, GIPR, SVRN) joining the gainers list after long absences, suggesting sector volatility and stock-picker opportunity within a broader market malaise.

Healthcare drove 32% of gainers WOK on a 5-day losers streak 5 names returned after long absences WOK · 5-day losers streak INM — first appearance AMST — first appearance

Market Regime

Tue, May 19, 2026 Neutral conf: high macro · prototype

Neutral −100 … +100 · + tailwind / − headwind

VIX18.1 p63 Drawdown-2.0% Held3d · building SinceMay 15

Top drivers: S&P vs 50d avg ▲ Small-cap leadership ▼ VIX percentile ▼

processId: history-market-regime

Market Indexes

Tue, May 19, 2026 4

S&P 500

7,354.96

−48.09

-0.65%

NASDAQ Composite

25,870.71

−220.02

-0.84%

Russell 2000

2,747.07

−28.03

-1.01%

VIX

18.06

+0.24

+1.35%

Biggest Gainers

Tue, May 19, 2026 50

INM

InMed Pharmaceuticals Inc.Healthcare

$1.60+$0.92

+135.1%

NASDAQ · Mkt cap $7.8 M

InMed announced a definitive merger agreement with Mentari Therapeutics, a migraine drug developer, backed by $290 million in financing, triggering a 135% single-day rally as the deal reshapes the company's pipeline and strategy.

The evidence clearly points to a transformational merger announcement as the primary driver. InMed entered into a definitive all-stock merger with Mentari Therapeutics, a spinout from biotech hub Paragon that is developing two migraine medications targeting patients inadequately served by existing therapies. The deal is supported by substantial private financing of $290 million expected to fund operations through key clinical milestones, addressing a critical concern for biotech investors. This signals a major strategic pivot for InMed toward migraine prevention, which has become an attractive market segment given unmet medical needs. The combination of merger-enabled access to clinical assets, financing certainty, and clear operational runway through key value-creating milestones typically justifies a sharp repricing upward in small-cap biotech stocks. The magnitude of the gain reflects the market's positive reception to both the asset quality and the financial structure underpinning execution.

AMPGZ

Amplitech Group, Inc. Series B Right

$0.58+$0.33

+132.0%

NASDAQ

No news headlines were found in the last 48 hours, so the 132% surge in AMPGZ Series B Rights on May 19 cannot be traced to a specific announced catalyst; the move likely reflects technical trading, delayed news absorption, or sentiment shift in a thinly-traded security.

The absence of any Yahoo Finance headlines in the recent period means we cannot anchor the move to earnings, guidance, contract wins, or other fundamental announcements. AMPGZ is a Series B rights offering, a derivative security tied to Amplitech Group's equity. Such instruments can experience outsized volatility relative to the underlying stock due to lower liquidity, leverage effects, and their use by traders betting on near-term equity moves. The 132% gain could reflect renewed interest in the underlying Amplitech common stock, a short squeeze in a thinly traded right, technical breakout trading, or absorption of older news not captured in the last 48 hours. Without headlines or context on Amplitech's fundamentals or the rights' terms, pinpointing the cause is not possible.

AMST

Amesite Inc.Technology

$1.73+$0.94

+120.1%

NASDAQ · Mkt cap $6.2 M

Amesite announced its largest enterprise customer deal to date—a 2,700-patient deployment of its NurseMagic AI documentation platform—driving a 120% single-day gain on validated commercial traction in healthcare AI.

The headlines establish a clear and material catalyst: on May 18–19, Amesite announced it had won its largest enterprise customer, a home care provider with a 2,700-patient census deploying NurseMagic, the company's AI-native documentation platform. Multiple sources confirm premarket and intraday rallies of 190–250% before settling at the +120% close. This is a straightforward commercial validation story. For a microcap AI healthcare play, winning a large-scale deployment from an enterprise customer proves product-market fit and scalability—both investor concerns for earlier-stage companies. The timing of the announcement (May 18) and the market's enthusiastic response (120%+ gain) align directly with news flow. No earnings surprise, FDA action, or other competing explanations are evident in the headlines provided.

CNEY

CN Energy Group. Inc.Basic Materials

$1.61+$0.88

+119.8%

NASDAQ · Mkt cap $5.0 M

No news headlines appeared in the last 48 hours, so the 119.77% surge in CNEY likely reflects a technical or market-driven event rather than a fundamental announcement.

The absence of any reported news in the past two days is notable given the stock's fourth-place ranking among daily gainers. For a low-priced NASDAQ stock like CNEY trading at $1.61, large percentage moves can stem from several non-news-driven sources: short covering or squeeze dynamics (small floats can amplify upward moves), technical breakouts above key resistance levels, broad sector rotation into energy equities, or delayed disclosure of material information not yet reflected in the Yahoo Finance RSS feed. Without access to intraday volume, options activity, or short interest data, the mechanism remains speculative. The stock's penny-stock-adjacent price point makes it susceptible to retail attention and momentum trading independent of fundamental catalysts.

AMPGR

Amplitech Group, Inc. Series A Right

$0.50+$0.25

+102.0%

NASDAQ

No news headlines were found in the last 48 hours, so the 102% jump in AMPGR Series A Rights cannot be directly attributed to a disclosed catalyst. The move likely reflects technical activity or delayed market reaction to previous events.

The absence of recent news makes direct causation difficult to establish. However, AMPGR Series A Rights are a specialized security tied to Amplitech Group's capital structure. Rights offerings are inherently volatile and can experience sharp moves based on: shifts in the underlying common stock price, changes in warrant or conversion mechanics, short covering in thinly traded securities, or market sentiment toward the parent company's restructuring or equity situation. Without headlines, the move could also reflect a delayed market reaction to an older announcement, technical bounces in micro-cap securities, or positioning ahead of a known corporate event. The rank as 5 biggest gainer suggests volume participation, but without corresponding news, the specific trigger remains unidentified.

NXXT

NextNRG Inc.Utilities

$0.82+$0.41

+100.0%

NASDAQ · Mkt cap $40 M

NextNRG reported record April revenue growth of 56% year-over-year and 195% Q1 revenue increase, marking the company's highest single-month revenue in history, which likely triggered the doubling of its stock price.

The stock's 100% gain aligns closely with two major positive developments disclosed within the past 48 hours. On May 19, NextNRG announced preliminary April 2026 revenue grew 56% year-over-year and set a company record for single-month revenue. This followed the May 18 Q1 2026 earnings call highlighting a 195% revenue increase for the quarter. While the company also disclosed liquidity constraints and net losses, the magnitude of revenue acceleration appears to have dominated investor sentiment. A May 17 analyst report cited impressive upside potential of 1624%, suggesting the market may have been primed for positive revenue news. The doubling of share price on a 56-month-over-month revenue growth announcement is consistent with growth-stock momentum trading, particularly in the renewable energy sector where top-line expansion often commands premium valuations despite near-term profitability challenges.

GIPR

Generation Income Properties, Inc.Real Estate

$0.43+$0.19

+75.9%

NASDAQ · Mkt cap $253 K

No news headlines were found in the last 48 hours, so the 75.89% gain on GIPR is unexplained by published reports; the move likely reflects either delayed news disclosure, technical trading activity, or market rumors not yet captured in major news feeds.

Generation Income Properties is a micro-cap real estate investment trust trading at $0.43, and the absence of any news coverage in the last two days is notable given the magnitude of the move. For a stock of this size and liquidity profile, a 76% single-day jump without concurrent headlines suggests either a delayed announcement that has not yet been widely reported, technical or algorithmic buying following a pre-market development, or retail/short-squeeze activity. Micro-cap REITs can be sensitive to changes in dividend policy, asset sales, or refinancing developments that move quickly through retail channels before reaching wire services. Without access to the actual catalyst, we cannot distinguish between legitimate fundamental news and speculative trading.

MTVA

MetaVia Inc.Healthcare

$1.88+$0.77

+69.4%

NASDAQ · Mkt cap $7.6 M

MetaVia announced presentation of obesity and cardiometabolic disease data at the ADA 2026 Scientific Sessions, triggering a 69% gain as investors responded positively to late-breaking clinical trial abstracts and sector-wide healthcare momentum.

MetaVia released news on May 18 that it will present three late-breaking abstracts on its cardiometabolic assets, including DA-1726, at a major diabetes and obesity conference. This type of announcement—especially "late-breaking" designations—typically signals novel or competitive clinical data that has impressed conference organizers enough to feature the work prominently. The timing aligns directly with the 69% jump on May 19. Concurrent sector strength in healthcare stocks (NYSE Healthcare Index gaining 1.1% on May 19) provided tailwinds, but MetaVia's outsized move relative to the sector suggests the company-specific news was the primary driver. For a clinical-stage biotech focused on cardiometabolic disease, positive presentation data can materially shift investor perception of pipeline value and competitive positioning.

SVRN

OceanPal Inc. Common StockIndustrials

$8.20+$2.72

+49.6%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours, so the 49.64% surge in SVRN cannot be directly attributed to a disclosed announcement. The move likely reflects technical buying, a short squeeze, or undisclosed market activity.

OceanPal Inc. is a small-cap shipping company, and the absence of any news in the Yahoo Finance RSS feed over the past two days makes it impossible to identify a specific corporate catalyst for the nearly 50% single-day gain. Small-cap stocks, particularly those in capital-intensive industries like shipping, can experience volatile moves on thin volume driven by short covering, retail accumulation, or sector rotation rather than fundamental news. Without access to earnings reports, contract announcements, debt restructuring, or other material events, the most likely explanations fall into technical or behavioral categories: short squeeze activity, options expiration effects, or market-neutral algorithmic repositioning. Shipping stocks can also be sensitive to commodity price movements or freight rate index changes that may not immediately appear in mainstream financial news.

OceanPal Inc.Industrials

$8.00+$2.52

+46.0%

CODX

Co-Diagnostics, Inc.Healthcare

$1.97+$0.60

+43.8%

NASDAQ · Mkt cap $6.9 M

Co-Diagnostics announced completion of an Ebola assay strategy for Bundibugyo virus following a WHO emergency alert, positioning the company to rapidly deploy diagnostic tests if outbreak conditions worsen, sparking investor interest in its diagnostic capabilities.

The company disclosed that it has completed development of an Ebola assay strategy and stands ready to deploy Bundibugyo virus testing if global outbreak conditions require expanded diagnostic response. This announcement directly addresses a current public health emergency flagged by the WHO, which creates near-term commercial opportunity for CODX's molecular diagnostics platform. The timing and specificity of the news—announcing preparedness for an active threat—likely attracted investors seeking exposure to companies positioned to benefit from pandemic or epidemic response scenarios. The stock's 43.8% single-day gain reflects market recognition of both the strategic relevance and potential revenue acceleration if the outbreak escalates and testing demand surges. However, the headlines do not specify any binding orders, revenue guidance, or clinical validation beyond the company's internal preparation statement.

ISPR

Ispire Technology Inc.Consumer Defensive

$2.15+$0.54

+33.1%

NASDAQ · Mkt cap $86 M

No news headlines were found in the last 48 hours, so the 33% gain likely reflects either a delayed market reaction to an earlier announcement, technical/short-covering activity, or an undisclosed development not yet captured by major news feeds.

The absence of any news in the Yahoo Finance RSS feed over the past 48 hours creates genuine uncertainty about what drove Ispire Technology's strong 33% rally to $2.15. For a micro-cap stock trading in the low double-digits, this magnitude of move typically correlates with either material corporate developments (earnings surprises, product launches, partnership announcements, regulatory approvals, or financing events), technical factors such as short covering or options-related buying pressure, or rumors circulating on retail trading forums that haven't yet reached mainstream financial media. Given that Ispire operates in cannabis and vaping hardware, the stock may also be responsive to shifts in industry sentiment, regulatory news affecting the sector broadly, or insider activity. Without documented headlines, attributing the move to any specific catalyst is speculative.

EDSA

Edesa Biotech, Inc.Healthcare

$11.95+$2.95

+32.8%

NASDAQ · Mkt cap $55 M

Edesa Biotech announced new clinical data on its lead drug paridiprubart for acute kidney injury to be presented at a major European nephrology conference, driving investor optimism and the 32.78% single-day gain.

The headline confirms Edesa will present additional data on paridiprubart at ERA Congress, a flagship European nephrology meeting, on May 19, 2026. For clinical-stage biotech companies, positive or anticipated clinical data presentations at major medical conferences typically drive significant single-day rallies, as they provide transparency on drug efficacy and safety in a credible peer-reviewed forum. The stock's position as the 13th biggest gainer suggests market-wide recognition of this catalyst. The announcement itself does not disclose whether the data is positive or negative, but investor behavior (a 33% jump) implies market participants either expect favorable results, view the presentation as a validation milestone, or both. Without details on the actual data outcome or historical context of this drug program, we cannot rule out that expectations were already pricing in success and this merely confirmed them.

VRAX

Virax Biolabs Group LimitedHealthcare

$0.31+$0.07

+31.5%

NASDAQ · Mkt cap $2.5 M

No news headlines were found in the last 48 hours, so the 31% gain likely reflects a technical bounce, delayed reaction to an earlier announcement, or short covering in a thinly-traded biotech stock.

The absence of recent news headlines makes it impossible to pinpoint a specific catalyst for VRAX's strong move today. Virax Biolabs is a small-cap biotech company trading at $0.31, which typically characterizes stocks with low liquidity and high volatility. In such securities, large percentage moves can occur from multiple sources: technical oversold conditions triggering relief buying, accumulation by retail investors following news that broke outside the 48-hour window, short squeezes due to limited float, or market-wide sector rotation into biotech. Without access to company announcements, SEC filings, clinical trial updates, partnership news, or other material disclosures released in the broader timeframe, attribution remains speculative. The timing of the move suggests either a delayed market reaction or an event not yet captured in the financial news RSS feeds provided.

SUGP

SU Group Holdings Limited Ordinary SharesIndustrials

$5.32+$1.24

+30.4%

NASDAQ · Mkt cap $6.9 M

SU Group announced an expanded AI-powered security offering on May 18, which likely drove the 30% gain as investors responded positively to the company's growth in the high-demand AI security market.

The headline from May 18 describes SU Group's announcement of a significant expansion of its AI-powered security solutions, framed as a response to surging global demand. This is a growth-oriented product announcement from an integrated security engineering services company. The timing aligns precisely with the stock's 30% jump on May 19, the day after the announcement. The market appears to have reacted favorably to the company's positioning in the AI security space, which has become a priority area for enterprises and governments. However, the headline provided is incomplete—we lack details on financial impact, contract wins, revenue guidance changes, or margin implications. The headline text cuts off mid-sentence, so the full scope of the announcement is unknown. Without seeing the complete announcement or any analyst commentary, we cannot rule out other contributing factors such as short covering, technical bounce, or accompanying guidance that might have amplified the reaction.

JEM

707 Cayman Holdings Limited Ordinary SharesConsumer Cyclical

$1.98+$0.44

+28.6%

NASDAQ · Mkt cap $2.8 M

No news headlines were found in the last 48 hours for JEM, so the cause of the 28.57% jump cannot be tied to a specific announced event. The move may reflect technical factors, unreported news, or general market sentiment toward the security.

The absence of any recent news coverage in the Yahoo Finance RSS feed for the 48 hours surrounding this significant gain makes it impossible to ground the move in a specific corporate announcement, earnings release, regulatory action, or strategic development. JEM is a Cayman Islands-domiciled holding company with relatively low absolute price, which suggests it may be more sensitive to technical trading, retail interest, or liquidity events. Possible explanations for this type of move in a low-priced security without concurrent news include short squeeze dynamics, options-related gamma effects, a delayed or non-traditional news source disclosure, or a broader sentiment shift in the micro-cap or offshore holding company space. Without confirmed news or detail on the company's business model and capital structure, pinpointing the catalyst remains speculative.

ADIL

Adial Pharmaceuticals, Inc.Healthcare

$2.06+$0.45

+28.0%

NASDAQ · Mkt cap $15 M

No news headlines were found in the last 48 hours, so the 27.95% gain likely reflects a technical bounce, delayed news pickup, or rumor rather than a confirmed corporate event.

Adial Pharmaceuticals is a small-cap biotech stock with limited analyst coverage and low trading volume, characteristics that make it susceptible to sharp intraday moves on minimal catalyst. The absence of any headline in the Yahoo Finance RSS feed in the prior 48 hours suggests the move was not driven by a major announced event such as an FDA decision, trial result, partnership, or earnings report. Possibilities include a technical reversal after prior weakness, accumulation by a motivated buyer, short covering given typical small-cap short interest, or a rumor or press release that has not yet been indexed by major financial news aggregators. Without additional information about volume, insider activity, or social media discussion, attribution remains speculative.

NEOV

NeoVolta Inc.Industrials

$2.02+$0.42

+26.3%

NASDAQ · Mkt cap $214 M

No news headlines were found in the last 48 hours, so the 26% gain on NEOV likely reflects technical trading, sector momentum, a delayed news flow, or market speculation rather than a disclosed catalyst.

NeoVolta Inc. posted a strong single-day gain of 26% to reach $2.02, landing it as the 18th biggest gainer on May 19, 2026, yet no news headlines appeared in the most recent 48-hour window on Yahoo Finance. This disconnect between price action and reported news is common in small-cap stocks and can stem from several sources. First, news may have been released but not yet indexed by the RSS feed or may have appeared on less mainstream channels that Yahoo does not cover immediately. Second, the move could reflect short covering or retail buying momentum if the stock has a high short interest or is trading near technical support levels. Third, sector tailwinds in energy storage or battery technology could be driving broad buying. Finally, unconfirmed rumors or social media activity sometimes trigger moves before formal announcements. Without headline evidence, we cannot pinpoint a specific corporate event or catalyst.

PHOE

Phoenix Asia Holdings Limited Ordinary SharesIndustrials

$15.76+$3.26

+26.1%

NASDAQ · Mkt cap $526 M

No news headlines were found in the last 48 hours for PHOE, so the 26% gain on May 19 cannot be attributed to a specific disclosed catalyst. The move likely stems from technical trading, delayed news circulation, or market rumor.

Phoenix Asia Holdings experienced a substantial single-day rally of 26%, ranking it among the day's top gainers, yet no corresponding news appeared in the Yahoo Finance RSS feed during the preceding 48 hours. This disconnect suggests either a lag in news distribution to the feed, an undisclosed or internally-known development, or purely technical factors. For small-cap stocks trading on major exchanges, catalysts typically include earnings releases, strategic partnerships, regulatory approvals, or insider activity. Without access to the company's filings or broader news sources beyond the provided feed, determining the specific trigger remains speculative. The absence of headlines does not rule out a real announcement; it may simply indicate timing misalignment or that the move was driven by trading mechanics rather than fundamentals.

TDTH

Trident Digital Tech Holdings LtdTechnology

$1.74+$0.34

+24.3%

NASDAQ · Mkt cap $2.3 B

Trident Digital Tech announced a five-pillar expansion strategy across Africa and Asia-Pacific on May 19, diversifying into cybersecurity, AI infrastructure, government tech, digital commerce, and agritech, likely driving the 24.29% gain.

The company unveiled a strategic pivot to position itself as a digital infrastructure holding company with exposure to five high-growth verticals in emerging markets. This represents meaningful expansion beyond its prior digital identity focus and signals management's confidence in capturing long-term scalable opportunities in underserved regions. The announcement directly addresses investor appetite for emerging-market exposure and diversified tech infrastructure plays. While the headline lacks quantified financial targets or immediate revenue catalysts, the breadth of the strategy and geographic focus appear to have resonated with the market. The timing aligns precisely with the stock's intraday surge, suggesting the announcement was the primary driver.

GLXG

Galaxy Payroll Group LimitedIndustrials

$1.00+$0.20

+24.2%

NASDAQ · Mkt cap $6.1 M

No news headlines were found in the last 48 hours for GLXG, so the 24% gain likely stems from technical trading, retail momentum, a delayed announcement not yet indexed by Yahoo Finance, or short-covering activity rather than a fundamental news catalyst.

Galaxy Payroll Group Limited's 24% single-day jump occurred without any identifiable news in the headline feed provided. This creates a significant gap between the price action and documented catalysts. For a micro-cap or lower-liquidity stock trading near the $1 mark, such moves often reflect technical factors: oversold bounces, short-squeeze dynamics, or retail social media momentum rather than company-specific fundamentals. It is also possible that a material announcement (earnings, guidance, partnership, or regulatory filing) occurred but has not yet propagated to major RSS feeds, or was posted to the company's own channels before wider distribution. Without access to the company's investor relations page, SEC filings, or real-time Nasdaq news, we cannot rule out a legitimate business catalyst that simply has not appeared in this snapshot's news sources.

MOVE

Corvex, Inc.Technology

$22.20+$3.76

+20.4%

SMX

SMX (Security Matters) Public Limited CompanyIndustrials

$8.03+$1.36

+20.4%

NASDAQ · Mkt cap $17 M

No news headlines were found in the last 48 hours, so the +20.39% gain cannot be attributed to a specific announced catalyst. The move likely reflects technical trading, sector sentiment, or undisclosed rumors in the market.

The absence of recent headlines is notable given SMX's substantial 20.39% single-day rally, placing it in the top 25 gainers on NASDAQ. For a security like SMX (a small-cap defensive technology/security firm), moves of this magnitude without simultaneous news coverage typically fall into a few categories: technical buying pressure, short-covering in a thinly traded security, sector rotation into cybersecurity or defense themes, or informal market discussion not yet reflected in major financial news sources. Given the lack of earnings announcements, partnership disclosures, or regulatory updates in the provided headlines, we cannot pinpoint a specific catalyst. This gap makes it difficult to assess whether the move is fundamental or sentiment-driven.

STEX

Streamex Corp.Financial Services

$1.19+$0.20

+20.2%

NXGL

NEXGEL, Inc.Healthcare

$0.61+$0.10

+20.1%

NASDAQ · Mkt cap $3.7 M

NEXGEL reported positive clinical data showing its hydrogel laser treatment patch reduced plume concentration by 95.6% and improved hair removal outcomes, likely driving the 20% single-day gain in the small-cap biotech stock.

The headline describes a completed randomized single-center IRB study with what appears to be favorable efficacy and safety results for NEXGEL's hydrogel patch technology in laser hair removal. The study showed statistically significant reduction in laser plume exposure, greater hair reduction, and reduced patient pain compared to control. For early-stage medtech or biotech companies, positive clinical data releases—especially those demonstrating safety and efficacy improvements—commonly trigger sharp single-day moves as they reduce development risk and validate the technology. This appears to be a genuine clinical milestone announcement rather than a speculative event. The stock's rank as the 25th largest gainer on the day is consistent with a small-cap making news-driven moves, though the 20% jump reflects both the positive data and the stock's low absolute price, which amplifies percentage swings.

CXAI

CXApp Inc.Technology

$0.17+$0.03

+20.0%

NASDAQ · Mkt cap $10 M

No news headlines were found in the last 48 hours, so the 20% gain on CXAI appears driven by either technical trading activity, delayed market reaction to older news, or untracked catalysts such as rumors or insider activity.

The absence of any recent news headlines makes it difficult to pinpoint a specific catalyst for the 20% intraday rally. CXAI is a micro-cap stock trading at $0.17, a price range typical of illiquid securities where small absolute dollar volumes can produce large percentage moves and where technical factors like short covering or thin-float dynamics often dominate price action. The jump to rank 26 among daily gainers despite no identified news suggests either a delayed market reaction to an older announcement not captured in the Yahoo Finance RSS feed, algorithmic or retail trading clustering, or possibly a rumor circulating outside major news channels. For stocks in this price tier, liquidity-driven moves and technical bounces are common even absent fundamental news.

XBP

XBP Global Holdings, Inc.Technology

$2.47+$0.41

+19.6%

NASDAQ · Mkt cap $35 M

No news headlines were found in the last 48 hours, so the 19.61% gain in XBP cannot be attributed to a specific announced event. The jump likely reflects technical trading, short covering, or undisclosed catalyst.

XBP Global Holdings posted a strong single-day gain of nearly 20%, ranking it among the day's top gainers, yet no news appeared in Yahoo Finance's RSS feed within the preceding 48 hours. This disconnect between price action and public announcements is common for lower-priced or lower-volume stocks. Without headline evidence, the move could stem from several typical mechanisms: short-squeeze dynamics if XBP has a high short interest or tight float, technical breakout above a resistance level, after-hours or pre-market developments not yet reflected in major news feeds, or a broker upgrade or guidance change released through a channel not captured in the RSS query. Additionally, micro-cap stocks can exhibit outsized volatility on low volume and speculative interest. Without access to intraday price data, Form 8-K filings, or sector-wide catalysts, pinpointing the precise trigger remains speculative.

LIVE

Live Ventures IncorporatedConsumer Cyclical

$11.19+$1.82

+19.4%

NASDAQ · Mkt cap $32 M

No headlines were found in the last 48 hours, so the 19.42% gain cannot be attributed to a publicly disclosed news event. The move likely stems from technical trading, short covering, or an undetected announcement.

Live Ventures is a small-cap holding company with a diverse portfolio of subsidiaries across retail, e-commerce, and industrial sectors. The stock moved 19.42% higher with zero news coverage in the prior 48 hours, which rules out traditional catalysts like earnings releases, guidance changes, or corporate actions as documented in major news feeds. For a micro-cap NASDAQ-listed company, such sharp single-day gains without press coverage typically reflect one of several patterns: technical momentum or algorithmic buying following a prior breakdown in resistance, a short squeeze if the float is tight or short interest is elevated, or a delayed or localized announcement not yet picked up by Yahoo Finance's news aggregator. Without access to intraday volume data, short interest levels, or insider filings from the snapshot date, pinpointing the precise cause is not possible. The stock's rank as the 28th biggest gainer suggests broad market participation rather than a single catalyst.

FBYD

Falcon's Beyond Global, Inc. Class A Common StockIndustrials

$13.28+$2.13

+19.1%

NASDAQ · Mkt cap $387 M

No news headlines were found in the last 48 hours to explain Falcon's Beyond Global's 19.06% gain, so the cause remains unclear without additional reporting or context.

Falcon's Beyond Global, a company in the experiential entertainment and technology sector, rose nearly 19% without any material news in the recent news cycle. This absence of headlines does not rule out a catalyst—the news may simply not have been picked up by Yahoo Finance's RSS feed yet, or the move could be driven by technical factors, options positioning, sector rotation, or undisclosed company announcements that have not yet reached mainstream financial media. Experiential tech stocks can be volatile and responsive to sentiment shifts, analyst upgrades, or industry developments that may take time to materialize in headlines. Without visibility into institutional activity, social sentiment, or proprietary company disclosures, the specific driver remains speculative.

MDBH

MDB Capital Holdings, LLC Class A commonFinancial Services

$3.85+$0.61

+18.8%

NASDAQ · Mkt cap $31 M

MDBH jumped 18.83% on May 19, but the only recent news is a PatentVest case study about Docana's AI patent work, which appears unrelated to MDB Capital Holdings and does not explain the move.

The provided headline concerns PatentVest's launch of case studies featuring work with Docana on AI intellectual property strategy. This news has no apparent connection to MDB Capital Holdings or its business operations, making it an unlikely direct catalyst for an 18.83% single-day gain. MDB Capital Holdings is a specialized finance company, and the PatentVest-Docana story involves patent IP services. The sharp move suggests either an undisclosed news catalyst not captured in the Yahoo Finance RSS feed, or a technical event such as short covering, options-related positioning, or renewed investor interest in a previously illiquid or depressed security. Without additional context on the stock's trading history, float, or short interest, the root cause remains unclear.

MGN

Megan Holdings Limited Ordinary SharesIndustrials

$0.18+$0.03

+18.7%

NASDAQ · Mkt cap $3.7 M

No news headlines were found in the last 48 hours, so the 18.67% gain on MGN is unexplained by public announcements; the move likely reflects technical trading, delayed news dissemination, or retail momentum in a low-priced stock.

The absence of any recent news headlines makes it impossible to anchor the price move to a specific corporate event. MGN trades at $0.18, which places it in the microcap category where liquidity is thin and percentage moves can be volatile even on modest dollar volume. Low-priced stocks are often subject to technical rebound bounces after sell-offs, short-covering rallies, or retail trading interest. Without access to Level 2 data, trading volume, or news timing, the most reasonable hypotheses are a technical reversal following oversold conditions, a delayed or embargoed announcement not yet picked up by Yahoo Finance, or momentum trading driven by the stock's appearance on a gainers list. None of these can be confirmed from the provided evidence.

EGG

Enigmatig LimitedIndustrials

$9.26+$1.45

+18.6%

AMEX · Mkt cap $87 M

No news headlines were found in the last 48 hours, so the 18.57% jump in EGG stock cannot be attributed to a specific announced event; the driver remains unknown without additional context.

The absence of recent news headlines despite an 18.57% single-day gain is notable. For a stock ranked 32 among daily gainers, the move is substantial enough to warrant explanation, but none is provided by the available news sources. This type of gap between price action and reported news can occur for several reasons: the catalyst could be a delayed market-wide technical event, accumulation based on unannounced developments not yet covered by major financial outlets, a response to broader sector momentum, social media discussion or retail interest that precedes formal news coverage, or an earnings-related surprise that has not yet been picked up by RSS feeds. Without access to real-time order flow, insider news, or social sentiment data, the specific trigger remains speculative. Small-cap or microcap stocks listed on AMEX sometimes experience outsized moves on thin volume or sentiment shifts that leave limited recorded trace in major news outlets.

SKLZ

Skillz Inc.Communication Services

$7.80+$1.20

+18.2%

NYSE · Mkt cap $130 M

No news headlines were found in the last 48 hours, so the 18% gain likely reflects technical trading, retail momentum, delayed reactions to older events, or untracked market rumors specific to the gaming or mobile esports sector.

Skillz is a mobile gaming and esports platform that typically experiences volatility tied to user growth announcements, partnership deals, platform milestones, or shifts in sentiment around the competitive gaming space. The absence of fresh headlines in the RSS feed does not rule out news reaching the market through other channels, earnings surprises, analyst upgrades, or social media-driven retail trading activity. Gaming and fintech-adjacent stocks have shown sensitivity to broader market sentiment shifts as well. Without specific catalysts named in the available news sources, the jump appears disconnected from breaking corporate announcements, making it difficult to identify the precise trigger.

KRKR

36Kr Holdings Inc.Communication Services

$3.86+$0.59

+18.0%

NASDAQ · Mkt cap $6.4 M

No news headlines were published in the last 48 hours for KRKR, so the 18% jump cannot be directly attributed to any specific disclosed event. The gain was likely driven by technical factors, delayed news digestion, or market rumors unconfirmed in major financial media.

KRKR experienced a substantial single-day rally of 18.04% to reach $3.86, yet no relevant news articles appear in the available headline feed from the past 48 hours. This disconnect suggests either that the catalyst was not captured by the RSS feed, was a delayed market reaction to older news, or was driven by non-fundamental factors. For a micro-cap Chinese tech company trading on NASDAQ, typical catalysts include earnings surprises, management announcements, strategic partnerships, or changes in regulatory stance affecting Chinese tech firms broadly. Alternatively, low liquidity in KRKR shares could amplify moves from modest volume spikes or short-covering. Without confirmed news, attributing this move to a specific business event would be speculative.

GTBP

GT Biopharma, Inc.Healthcare

$0.43+$0.07

+18.0%

NASDAQ · Mkt cap $11 M

No news headlines were found in the last 48 hours, so the 18% gain cannot be attributed to a documented company announcement or market event. The move is likely driven by technical factors, retail interest, or undisclosed news.

GT Biopharma is a small-cap biotech stock with limited liquidity and analyst coverage, making it prone to outsized moves on minimal volume or sentiment shifts. The absence of news in the Yahoo Finance RSS feed over the past two days means we cannot point to earnings, regulatory action, clinical trial results, partnership announcements, or guidance changes as the documented cause. For microcap biotech stocks trading under fifty cents, gains of this magnitude can stem from several sources: short covering or squeeze dynamics, social media momentum, delayed news dissemination that hasn't yet appeared in major feeds, or technical breakouts from support levels. Without access to insider trading data, options activity, or real-time social sentiment, attribution remains speculative. The fact that it ranked as the 35th biggest gainer suggests this was a real move with some volume behind it, but the lack of corresponding headline coverage points toward either a structural market factor or news that simply has not yet propagated to major RSS feeds.

SAGT

SAGTEC GLOBAL LtdTechnology

$1.03+$0.16

+17.7%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours, so the 17.71% gain likely reflects technical trading, retail momentum, a delayed announcement not yet indexed by Yahoo Finance, or sector-wide movement rather than company-specific developments.

The absence of recent news makes identifying a definitive catalyst difficult. SAGTEC Global is a smaller-cap NASDAQ stock, and moves of this magnitude in stocks trading near $1.00 can be driven by several non-news factors: technical breakouts or short covering, retail trading activity, sector rotation, or delayed disclosure of corporate events that haven't yet appeared in major news feeds. Without access to intraday volume data, insider trading filings, or micro-cap message boards, we cannot rule out a rumor-driven rally or institutional accumulation. It is also possible that a material announcement was made through other channels before being indexed by Yahoo Finance RSS, or that the move reflects catch-up trading following a prior-day news event outside the 48-hour window provided.

BLIV

BeLive HoldingsTechnology

$2.60+$0.39

+17.6%

NASDAQ · Mkt cap $25 M

No news headlines were found in the last 48 hours, so the 17.65% gain likely reflects technical trading activity, delayed news pickup, or market speculation in a lower-liquidity micro-cap stock rather than a fundamental catalyst.

The absence of any headlines from Yahoo Finance in the past 48 hours means we cannot point to a specific earnings report, contract win, regulatory approval, or strategic announcement as the driver. BLIV is a micro-cap stock trading at $2.60, which makes it susceptible to technical bounces, short covering, retail trading momentum, and delayed news dissemination. Stocks in this price range often gap on sentiment shifts or algorithmic activity without corresponding mainstream news coverage. It is possible that news exists but has not yet been indexed by the RSS feed, or that the move is purely technical in nature. Without additional context about BLIV's business, recent insider activity, or float structure, we cannot distinguish between a delayed positive announcement, a short squeeze, or sector-wide momentum.

SGMO

Sangamo Therapeutics, Inc.Healthcare

$0.15+$0.02

+16.8%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours, so the 16.77% gain on SGMO likely reflects technical trading, short-covering, or delayed market reaction to an untracked catalyst.

Sangamo Therapeutics is a gene-editing biotech company with a volatile price history. The stock's location at $0.15 suggests it has faced significant headwinds, and at that price level, small absolute dollar moves generate large percentage swings. With no recent news in the Yahoo Finance RSS feed to explain the jump, the gain could reflect several possibilities: short covering or squeeze activity common in deeply depressed biotech stocks, technical rebound from an oversold condition, delayed reaction to an event covered outside the provided news sources (such as a clinical trial update, partnership announcement, or insider trading activity), or general sector momentum in gene therapy or biotech. Without access to news beyond the 48-hour window or intraday catalyst confirmation, the specific trigger remains unidentified.

SNAL

Snail, Inc. Class A Common StockCommunication Services

$1.12+$0.16

+16.7%

OPTX

Syntec Optics Holdings, Inc.Technology

$7.63+$1.08

+16.5%

NASDAQ · Mkt cap $337 M

Syntec Optics announced deep tech deliveries for defense, space, and hyperscale AI applications on May 19, which likely drove the 16.49% intraday gain as the headline signals business momentum in high-growth end markets.

The news headline indicates that Syntec Optics made an announcement on the same day as the stock's strong 16.49% jump. The press release focuses on the company's "deep tech deliveries" for defense, space, and hyperscale AI sectors, which are all currently high-priority market segments attracting investor attention. The timing and sector relevance suggest investors interpreted this as validation of the company's strategy and market traction. However, the headline provided is only a summary line; the full press release content is truncated, so the specific magnitude of deliveries, revenue implications, contract values, or forward guidance are unknown. This limits certainty about whether the move reflects a major contract win, production milestone achievement, or more routine business update that happened to land on a favorable market day.

Visionary Holdings Inc.Consumer Defensive

$0.30+$0.04

+16.3%

NASDAQ · Mkt cap $157 K

No news headlines were found in the last 48 hours for GV, so the 16.34% gain likely reflects technical trading activity, delayed market reaction to an earlier announcement, or sector-wide momentum in penny stocks.

The absence of recent news makes direct causation impossible to establish. GV is a micro-cap trading at $0.30, a category prone to outsized moves on minimal volume, short covering, retail interest, or sector rotation. The stock's rank as the 41st biggest gainer suggests it was part of a broader penny-stock or biotechnology rally if Visionary operates in a sector experiencing tailwinds. Without headlines from the past 48 hours, we cannot rule out three scenarios: first, a material announcement was made more than 48 hours ago but is only now being priced in; second, the move is driven by technical factors such as breaking through a resistance level or short squeeze activity; third, news exists but was not indexed by the Yahoo Finance RSS feed. The lack of news does not prove absence of a catalyst, only absence of public record in the provided sources.

BDTX

Black Diamond Therapeutics, Inc.Healthcare

$3.00+$0.42

+16.3%

NASDAQ · Mkt cap $116 M

Black Diamond Therapeutics announced an investor webcast scheduled for May 21 to present updated Phase 2 trial results for silevertinib in lung cancer, likely driving anticipation of positive data ahead of the presentation.

The company issued a press release on May 19 announcing a webcast for May 21 where it will highlight updated Phase 2 trial results for silevertinib in first-line EGFR-mutant NSCLC. For clinical-stage oncology companies, announcements of upcoming data presentations often trigger positive price action when investors anticipate favorable results. The 16% gain on the day of the announcement suggests market participants view the upcoming data disclosure as potentially material. However, the press release itself does not reveal the actual trial results, only that they will be presented. The stock movement reflects forward-looking optimism about what will be disclosed in two days rather than confirmation of efficacy or safety data.

AQB

AquaBounty Technologies, Inc.Consumer Defensive

$1.04+$0.14

+15.5%

NASDAQ · Mkt cap $6.8 M

No headlines found in the last 48 hours to explain the 15.49% jump in AquaBounty stock. The move is likely driven by technical trading, delayed news dissemination, or sector-wide sentiment shifts.

No recent news headlines are available to account for AquaBounty's sharp 15.49% gain on May 19, 2026. This absence does not mean no catalyst exists—it may indicate a news event occurred outside the Yahoo Finance RSS feed window, or the market is reacting to an announcement made before the 48-hour cutoff. AquaBounty operates in aquaculture and biotech, sectors sensitive to regulatory developments such as FDA approvals, environmental policy changes, or partnerships. Additionally, small-cap biotech stocks often experience volume-driven rallies from technical bounce-backs, short covering, or retail attention shifts. Without confirmed headlines, the cause remains speculative across these broad categories.

RDGT

Ridgetech Inc.Healthcare

$1.59+$0.21

+15.2%

NASDAQ · Mkt cap $2.9 M

No news headlines were found in the last 48 hours for RDGT, so the 15.22% gain on May 19 cannot be attributed to a specific announced event and likely reflects technical, rumor-based, or delayed news factors.

The absence of any Yahoo Finance headlines in the past 48 hours creates a clear gap between the stock's strong price action and public information channels. A 15.22% single-day move for a stock trading at $1.59 is substantial and typically warrants a news catalyst. Possible explanations include a technical rebound from oversold conditions, short-squeeze dynamics common in low-priced stocks, delayed dissemination of an earlier announcement not yet syndicated to major feeds, or social media-driven momentum that hasn't yet reached traditional financial news outlets. Penny and micro-cap stocks like RDGT often experience outsized intraday volatility driven by retail attention or institutional positioning rather than fundamental catalysts. Without access to intraday news wires, press releases, or SEC filings released May 19 itself, the specific driver remains unidentified.

NNNN

Anbio Biotechnology Class A Ordinary SharesHealthcare

$32.34+$4.19

+14.9%

NASDAQ · Mkt cap $366 M

No specific news about Anbio was provided; the stock likely benefited from inclusion in a "undiscovered gems" list circulating on May 19, or from broader biotech sector momentum, but the precise catalyst remains unclear.

The two headlines provided discuss general US market opportunities and "undiscovered gems" without naming Anbio specifically. Neither headline discloses company-specific news such as clinical trial results, regulatory approvals, earnings beats, partnerships, or guidance changes. The +14.88% gain ranks Anbio 45th among daily gainers, suggesting it moved in line with sector or thematic momentum rather than isolated positive news. One reasonable inference is that Anbio may have been mentioned or highlighted in financial commentary as an undervalued opportunity, or it may have benefited from a general biotech rally or short-squeeze activity. Another possibility is that news breaking outside the 48-hour window or on other platforms drove the move. Without company-specific developments in the provided headlines, attribution remains speculative.

GCTK

GlucoTrack, Inc.Healthcare

$0.55+$0.07

+14.8%

NASDAQ · Mkt cap $3.7 M

No news headlines were found in the last 48 hours to explain GCTK's 14.84% gain, so the catalyst remains unclear; the move could reflect delayed news dissemination, technical trading, or market-driven speculation.

GlucoTrack is a micro-cap stock trading at $0.55, and the absence of any recent news headlines in the Yahoo Finance RSS feed over the past two days makes it impossible to attribute the gain to a specific corporate announcement, regulatory decision, or earnings event. For stocks in this price range and market cap, daily moves of this magnitude are not uncommon and can be driven by several non-headline factors: technical rebounds after prior weakness, retail trading activity, short covering if the stock has significant short interest, or news that has not yet been picked up by major financial media. Without access to press releases, social media sentiment, or less-mainstream news sources, the true catalyst cannot be identified from the available evidence. The lack of materiality in coverage—or the delay in coverage reaching standard feeds—is itself a characteristic of very small-cap stocks.

MLP

Maui Land & Pineapple Company, Inc.Real Estate

$17.13+$2.16

+14.4%

NYSE · Mkt cap $316 M

No news headlines were published in the last 48 hours to explain the 14.43% jump in MLP stock. The move likely stems from a delayed news release, technical trading, or a corporate announcement not yet reflected in the financial news feed.

Maui Land & Pineapple Company is a small-cap agricultural and real estate company, and a 14.43% single-day gain ranks among the day's top 50 movers, suggesting a meaningful catalyst. However, no financial headlines are available in the provided 48-hour window to identify a specific cause. For stocks of this type and size, typical catalysts include earnings surprises, dividend announcements, real estate sales or portfolio developments, restructuring news, activist involvement, or shifts in commodity prices affecting agricultural operations. The absence of headlines does not rule out a material announcement being made; it may indicate the news source lag, a delayed wire dissemination, or an event that occurred after the headline snapshot was captured. Technical factors such as low liquidity amplifying small volume moves are also possible for micro-cap securities.

STAK

STAK Inc. Ordinary SharesEnergy

$1.35+$0.17

+14.4%

NASDAQ · Mkt cap $29 M

No news headlines were found in the last 48 hours to explain STAK's 14.41% gain, so the driver remains unclear; the move may reflect technical trading, an untracked announcement, or market sentiment shift.

STAK Inc. jumped 14.41% to $1.35 on May 19, 2026, but zero news appeared in the Yahoo Finance RSS feed over the preceding two days. This absence of coverage does not rule out a catalyst. Possible explanations for a micro-cap NASDAQ stock of this magnitude include a technical bounce off support levels or short covering if the stock has meaningful short interest. Alternatively, the catalyst could be a press release or event that has not yet been indexed by major news aggregators, or trading related to options expiration. Without access to real-time filings, earnings calendars, or detailed short interest data, pinpointing the specific driver is not feasible from the provided evidence.

LXEH

Lixiang Education Holding Co., Ltd.Consumer Defensive

$1.43+$0.18

+14.4%

NASDAQ · Mkt cap $3.1 M

No news headlines were found in the last 48 hours for LXEH, so the 14.4% gain cannot be attributed to a specific announced catalyst. The move likely reflects technical trading, a delayed market reaction to prior news, or retail interest in a low-priced stock.

LXEH showed a substantial single-day gain of 14.4% to $1.43, ranking it among the day's top 49 gainers. However, no news headlines appeared in the Yahoo Finance RSS feed for the prior 48 hours, meaning no earnings report, company announcement, regulatory action, or other identifiable corporate catalyst can be confirmed as the trigger. For a Chinese education stock trading at this price level, possible explanations include a technical rebound after prior weakness, delayed market reaction to older news not captured in the 48-hour window, short covering, or broad sector rotation into educational equities. Without access to trading volume data, options activity, or prior context on the stock's recent price history, pinpointing the specific mechanism remains speculative.

PIII

P3 Health Partners Inc.Healthcare

$10.49+$1.32

+14.4%

NASDAQ · Mkt cap $1.8 B

PIII gained 14.39% on May 19th following a report that Trump's critical market remark on May 18th drove a rally in forgotten micro-cap stocks under $30, with PIII among unlikely winners in the turnaround.

The only headline provided is a market commentary article from May 18th indicating that President Trump's critical remark about Americans' financial situation sparked volatility that benefited small-cap and micro-cap stocks trading under $30 in the "forgotten corners of the market." PIII, trading at $10.49, fits this category. However, the headline does not explain the specific mechanism—whether this represents mean reversion after Trump-related selloffs, sector rotation, or contrarian positioning. The article is descriptive rather than causal; it flags that small-cap stocks rallied but does not confirm PIII received any company-specific positive news. No earnings, guidance, product approval, partnership, or operational catalyst is named in the provided headlines. The move appears driven by market-level sentiment and positioning rather than PIII fundamentals.

Biggest Losers

Tue, May 19, 2026 50

JYD

Jayud Global Logistics LimitedIndustrials

$1.88−$3.64

-65.9%

NASDAQ · Mkt cap $8.5 M

JYD crashed 65.94% with no news headlines in the last 48 hours, suggesting a sudden market event, company announcement, or technical catalyst that has not yet been reported by major financial news outlets.

The absence of any headlines in the last 48 hours combined with an extreme single-day loss of nearly 66% is striking and problematic for root-cause analysis. Jayud Global Logistics is a smaller-cap logistics firm on NASDAQ, and moves of this magnitude typically correlate with major negative catalysts such as earnings misses, guidance cuts, covenant violations, insider selling disclosures, delayed filings, or delisting warnings. It is also possible the stock experienced a technical event such as a short squeeze reversal, a gap-down open on pre-market news not yet indexed by Yahoo Finance RSS, or a halt-and-resume volatility spike. Without corroborating headlines, all explanations remain speculative. The delay between the price action and news indexing is also plausible, particularly for smaller-cap stocks with lower analyst coverage.

ONCO

Onconetix, Inc.Healthcare

$0.12−$0.19

-61.6%

NASDAQ · Mkt cap $2.8 M

Onconetix announced a 1-for-10 reverse stock split on May 19, 2026, which mechanically reduced the share price by approximately 90% while preserving market capitalization; the 61.56% observed drop likely reflects both the split adjustment and concurrent negative market sentiment toward the stock.

The headline confirms that Onconetix announced a reverse stock split (1-for-10) on the same day as the 61.56% price decline. A 1-for-10 reverse split theoretically reduces the nominal share price by 90%, converting 10 old shares into 1 new share at 10 times the previous price. However, the actual closing price of $0.12 represents a roughly 61.56% drop from the prior close, suggesting the stock closed lower than the mechanical split adjustment alone would predict. This gap implies that in addition to the split, the market applied negative valuation pressure to the stock itself. Reverse splits are often viewed negatively by investors because they are frequently associated with financial distress, dilution history, or insufficient share price recovery. The announcement itself may have triggered selling pressure beyond the pure mechanics of the split. No other news directly addresses ONCO's fundamentals, operational performance, or catalysts on this date.

YMAT

J-Star Holding Co., Ltd. Ordinary SharesBasic Materials

$0.69−$0.72

-51.1%

NASDAQ · Mkt cap $7.3 M

No news headlines were available in the last 48 hours, so the 51% single-day drop cannot be attributed to a specific reported event. The cause remains unclear without additional information.

The absence of recent news headlines makes it impossible to identify a concrete catalyst for this severe decline. J-Star Holding Co., Ltd. (YMAT) is a small-cap stock trading at $0.69, which typically means it is thinly traded and can be sensitive to various pressures including technical selling, margin liquidations, delayed news from prior days that market participants are only now pricing in, private company developments not yet reported publicly, or shifts in investor sentiment toward the sector. Without access to broader market context, earnings surprises, regulatory filings, or insider transactions, the specific driver of this 51% loss remains speculative. The lack of headline coverage itself may suggest either that news has not yet been disseminated, or that the move is driven by non-public information or technical/liquidity factors.

WOK

WORK Medical Technology Group Ltd.Healthcare

$0.24−$0.15

-38.2%

NASDAQ · Mkt cap $5.2 M

No news headlines were found in the last 48 hours to explain the 38% drop in WOK stock, so the cause remains unknown; likely drivers could include delayed financial results, insider selling, technical breakdown, or untracked market news.

No recent news was reported in the Yahoo Finance RSS feed within the last 48 hours surrounding WOK's sharp 38% decline. Without identified catalysts such as earnings misses, regulatory setbacks, or guidance cuts, the drop is difficult to ground in specific company events. For a micro-cap medical technology stock trading at $0.24, possible explanations include delayed or poor quarterly results not yet widely reported, insider share sales, a failed clinical trial or regulatory rejection, loss of a major customer or partnership, or simple technical breakdown in a thin, low-liquidity name. The absence of news headlines does not rule out that material company-specific information exists; it may simply not have reached major news aggregators yet or been overlooked in coverage of larger movers.

CMND

Clearmind Medicine Inc.Healthcare

$0.24−$0.14

-37.8%

NASDAQ · Mkt cap $2.8 M

Clearmind announced a 1-for-10 reverse share split on May 19, which typically signals financial distress and dilution concerns, likely overwhelming a positive tirzepatide combination study announcement from the prior day.

The headline evidence shows two conflicting signals. On May 18, Clearmind announced a preclinical research agreement to evaluate its MEAI compound in combination with tirzepatide, a blockbuster GLP-1 obesity drug, which is operationally positive for the pipeline. However, on May 19 the same day as the price collapse, the company announced a 1-for-10 reverse share split. Reverse splits are typically executed by companies facing NASDAQ minimum bid price requirements and signal financial stress or runway concerns. While the reverse split mechanically adjusts share count and price, it is usually interpreted by the market as a negative indicator of company health. The timing suggests the reverse split announcement overwhelmed the preceding positive clinical news, causing the sharp 37.83% single-day drop. Investors in early-stage biotech are highly sensitive to capital structure signals, which often matter more than near-term pipeline milestones.

AUUD

Auddia Inc.Technology

$1.60−$0.77

-32.5%

NASDAQ · Mkt cap $5.5 M

Auddia shares plunged 32% despite releasing two positive announcements about its LT350 parking-lot AI infrastructure opportunity, suggesting investors may have interpreted the news as promotional rather than materializing into concrete contracts or revenue.

On the surface, the timing is puzzling: Auddia published two bullish statements within 48 hours highlighting a large AI datacenter opportunity (up to 960,000 GPUs via a REIT partnership) and citing favorable market pricing benchmarks from a SharonAI contract filing. However, the sharp decline suggests the market discounted or rejected the narrative. Possible explanations include skepticism that the LT350 concept remains speculative with no binding agreements announced, concerns that the company is making lofty claims without near-term revenue visibility, or broader sector weakness in AI infrastructure plays. It is also possible an unrelated catalyst such as insider selling, analyst downgrade, or negative social media narrative drove the move, but no such evidence appears in the provided headlines. The stock's rank as the sixth biggest loser hints at sector-wide or company-specific pressure beyond the news itself.

BTM

Bitcoin Depot Inc.Financial Services

$0.56−$0.22

-28.2%

CREG

Smart Powerr Corp.Utilities

$0.46−$0.16

-26.1%

NASDAQ · Mkt cap $499 K

Smart Powerr Corp. announced a $2 million registered direct offering on May 19, which typically triggers sharp sell-offs due to dilution concerns and immediate shareholder equity impact.

The company disclosed a definitive agreement for a registered direct offering (RDO) of $2 million in equity on the same day as the 26% decline. RDOs are equity issuances that dilute existing shareholders and often signal capital constraints or urgent funding needs. The timing of the announcement—released at 17:35 UTC after market hours—means the market had limited time to react during regular trading, but the headline clearly indicates this offering was the trigger. The news headline is truncated and does not specify pricing, discount level, or warrant terms, but the announcement itself is sufficient to explain the magnitude of the drop, as investors immediately repriced the stock downward to account for the dilution effect. No other conflicting news is evident in the provided sources.

MWC

Micware Co., Ltd. American Depositary SharesConsumer Cyclical

$4.72−$1.63

-25.7%

NASDAQ · Mkt cap $88 M

No news headlines were published in the last 48 hours for MWC, so the 25.67% drop cannot be directly attributed to a specific announced event. The decline likely stems from a delayed earnings release, analyst downgrade, or broad market sector weakness.

The absence of recent news headlines on Yahoo Finance in the 48-hour window makes direct attribution impossible. A drop of this magnitude typically correlates with material corporate announcements such as earnings misses, guidance cuts, or negative regulatory developments. For a microcap ADR like Micware, potential causes include delayed or unexpectedly weak quarterly results, short-seller activity, insider selling, or contagion from sector-wide declines in technology or semiconductor stocks. It is also possible that the news originated on regional exchanges or Chinese business feeds before reaching US market awareness, or that a significant announcement occurred just before market close and the headline indexing lag delayed its appearance in the RSS feed. Without access to the actual catalyst, any specific explanation remains speculative.

BNZI

Banzai International, Inc.Technology

$3.81−$1.27

-25.0%

NASDAQ · Mkt cap $5.6 M

No news headlines were published about BNZI in the last 48 hours, so the 25% single-day drop likely stems from an undisclosed event, technical breakdown, or delayed announcement not yet captured by major financial news feeds.

The absence of any headlines in the provided Yahoo Finance RSS feed over the past 48 hours makes it impossible to pinpoint a specific catalyst for BNZI's sharp 25% decline. For a stock of this apparent size and exchange listing, a move of this magnitude typically correlates with material corporate events such as earnings misses, guidance cuts, insider selling disclosures, regulatory setbacks, or significant contract losses. However, none of these are documented in the available news. An alternative possibility is that news did break but has not yet been indexed by the RSS aggregator, or the stock experienced a technical selloff driven by momentum or sector rotation. Without access to real-time alert systems, press releases, or SEC filings, the true driver remains unknown. The most prudent assessment is that something material likely occurred but is simply not reflected in the headlines provided.

LICN

Lichen International LimitedIndustrials

$2.83−$0.94

-24.9%

NASDAQ · Mkt cap $21 M

No news was reported in the last 48 hours for LICN, so the 24.93% drop cannot be attributed to a specific disclosed catalyst. The decline likely reflects either technical selling pressure, a delayed announcement, or broader market or company-specific concerns.

Yahoo Finance's RSS feed returned no headlines for Lichen International Limited in the preceding 48 hours, making it impossible to tie the sharp 24.93% single-day decline to a specific corporate action, earnings report, regulatory decision, or contract announcement. In the absence of reported news, such a large move in a microcap stock could stem from several categories of causes: a material announcement not yet picked up by major news wires, technical capitulation after a period of weakness, insider or institutional selling pressure, a delayed earnings or guidance miss becoming public informally, short covering or squeeze reversal, or broader sector rotation. Without access to real-time trading data, insider filings, or company press releases released outside standard news channels, the precise trigger remains unknown.

AIIO

Robo.ai Inc.Consumer Cyclical

$4.24−$1.36

-24.3%

NASDAQ · Mkt cap $487 M

No news directly explaining the 24% drop was provided; the only headline describes a routine international exhibition debut by a subsidiary, which is unlikely to trigger such a sharp decline.

The only recent headline available is a routine business announcement about Neurovia AI, Robo.ai's subsidiary, participating in an international security exhibition in Abu Dhabi. This is a positive or neutral event that would not reasonably explain a 24% single-day loss. The sharp decline likely stems from a catalyst not captured in the provided headlines. For a small-cap AI and robotics company trading at this price level, common drivers of such moves include disappointing earnings or guidance, broader sector weakness, analyst downgrades, insider selling signals, short interest squeezes reversing, or undisclosed company-specific developments. Without access to earnings releases, SEC filings, or market commentary from the relevant trading day, the specific trigger remains unclear.

RPGL

Republic Power Group Limited Class A Ordinary SharesTechnology

$0.24−$0.07

-23.8%

NASDAQ · Mkt cap $2.6 M

No news headlines were found in the last 48 hours to explain RPGL's 23.79% drop, so the cause remains unclear; the decline may reflect technical selling, delayed negative announcements, or broader micro-cap weakness.

The absence of any headlines in the last 48 hours makes it impossible to tie this sharp 23.79% decline to a specific corporate event, earnings miss, regulatory action, or strategic announcement. For a small-cap stock like RPGL trading at $0.24, possible explanations include technical breakdown below a support level, liquidation by holders, delayed negative news not yet picked up by major feeds, or contagion from sector weakness. Micro-cap and penny stocks are also prone to higher volatility and can experience sharp moves on low volume or rumor rather than confirmed news. Without access to SEC filings, insider transactions, or real-time trading data, attributing this move to any particular catalyst would be speculation. The evidence simply does not support a definitive cause.

YYGH

YY Group Holding LimitedIndustrials

$0.81−$0.24

-22.8%

NASDAQ · Mkt cap $4.5 M

YYGH fell 22.83% despite announcing an expansion into Malaysia's Melaka hospitality market, suggesting the market either views the expansion negatively, reacted to an undisclosed detail in the full release, or sold on unrelated broader weakness or technical factors.

The only headline provided announces a geographic expansion into Malaysia, typically viewed as a growth-positive development for an Asia-focused AI workforce management and facility services company. A 22.83% single-day drop is severe and contradicts the ostensibly bullish nature of the news. This disconnect suggests either the market interpreted specific details in the full press release unfavorably (e.g., capex requirements, margin dilution, or competitive concerns in that market), or the decline stems from factors unrelated to this announcement such as sector rotation, broader equity selloff, short covering reversal, or technical breakdown. Without access to the full press release or concurrent market events, we cannot isolate the precise cause. Stocks in emerging-market-focused software and services sometimes face skepticism around execution risk or capital efficiency, which could amplify a negative read on expansion plans.

CPOP

Pop Culture Group Co., LtdCommunication Services

$0.24−$0.07

-22.7%

NASDAQ · Mkt cap $4.8 M

No news headlines were found in the last 48 hours to explain the 22.68% drop in CPOP stock, suggesting the decline may be driven by technical selling, broader market weakness, or undisclosed catalysts not captured in the available news feed.

The absence of any news in the Yahoo Finance RSS feed over the past two days makes it impossible to pinpoint a specific corporate event responsible for the sharp decline. Pop Culture Group Co., Ltd is a micro-cap NASDAQ stock trading at $0.24, a price level typically associated with high volatility and thin liquidity. In this segment, large percentage moves often stem from technical factors such as stop-loss cascades, short covering reversals, options expiration effects, or broader market selloffs in growth or speculative equities. Alternatively, company-specific news may have circulated through channels not reflected in the RSS feed sampled, or the move could reflect delayed market reaction to older announcements. Without concrete news evidence, any explanation remains speculative.

QUCY

Mainz Biomed N.V.Healthcare

$2.56−$0.75

-22.6%

NASDAQ · Mkt cap $15 M

The sharp 22.58% drop does not align with the recent news headlines, which describe positive defense contract initiatives, patent filings, and leadership appointments at Quantum Cyber—suggesting the sell-off may reflect broader market sentiment, valuation concerns, or undisclosed company-specific…

The provided headlines from the past 48 hours all describe constructive developments for Quantum Cyber: patent applications for defense technologies, formation of a new defense subsidiary with appointed executives, and participation in a major defense industry conference. None of these announcements are typically associated with stock declines of this magnitude. This disconnect suggests the price drop is either driven by factors absent from the headlines (such as disappointing earnings, cash position concerns, or dilution announcements), or reflects a broader sell-off in the biotech or defense tech sector unrelated to Mainz Biomed's specific news cycle. Given that the stock ticker QUCY appears to be associated with Quantum Cyber based on the news content rather than Mainz Biomed, there may also be a data mismatch that complicates the analysis. Without earnings data, guidance changes, or negative regulatory news, the underlying driver remains unclear.

IPST

IP Strategy Holdings, Inc.Consumer Defensive

$5.81−$1.67

-22.3%

HCWB

HCW Biologics Inc.Healthcare

$1.06−$0.28

-20.9%

NASDAQ · Mkt cap $3.7 M

No specific news about HCWB was provided; the 20.9% drop on 2026-05-19 likely reflects broader market volatility or company-specific developments not captured in the available headlines.

The only headline in the 48-hour window references Trump's market-moving remarks and mentions that micro-cap stocks under $30 were "unlikely winners," but this article does not specifically mention HCWB or explain why it fell. HCWB at $1.06 is a micro-cap biotech stock trading well below $30, making it sensitive to both sentiment shifts and illiquidity. For a stock in this category, a 20.9% single-day decline could stem from several sources: clinical trial failure or delay, insider selling, short covering reversal, regulatory setback, dilutive financing announcement, or simple forced selling during a broader market correction. Without headlines directly addressing HCWB's fundamentals or a specific corporate action, the root cause remains unidentified. The micro-cap biotech sector is particularly prone to sudden moves on limited trading volume and news flow.

RUBI

Rubico Inc.Industrials

$1.37−$0.36

-20.8%

NASDAQ · Mkt cap $3.2 M

No news headlines were available in the last 48 hours for RUBI, so the 20.81% single-day drop cannot be directly attributed to a specific announced event. The decline is likely driven by technical selling, market sentiment, or undisclosed corporate news.

The absence of any news coverage in the RSS feed over the past two days makes it difficult to pinpoint a definitive cause for RUBI's sharp decline. For a stock trading at $1.37 on NASDAQ, typical catalysts for large single-day drops include unexpected earnings misses, insider selling, delisting warnings, debt covenant breaches, loss of major contracts, or clinical trial failures if the company is biotech-related. It is also possible that relevant news was published outside the monitored RSS feed, that trading volume spiked on technical or sentiment-driven factors, or that the company issued guidance or corporate updates through a channel not captured here. Without access to intraday volume, sector performance, or broader market context for May 19, 2026, we cannot rule out correlation with macro events or sector rotation either.

CDT

CDT Equity Inc.Healthcare

$1.20−$0.30

-20.0%

CPSH

CPS Technologies CorporationTechnology

$4.30−$1.05

-19.6%

NASDAQ · Mkt cap $77 M

No news headlines were found in the last 48 hours to explain CPSH's 19.63% drop, so the cause remains unclear without additional reporting or company announcements.

The absence of any recent news in the Yahoo Finance RSS feed over the past 48 hours means we cannot ground the decline in a specific announced event such as earnings results, guidance revision, contract loss, or regulatory action. CPS Technologies is a small-cap industrial materials company, and stocks of this size can experience sharp moves on limited volume, insider trading signals, short covering reversals, or delayed disclosure of material events not yet picked up by major news outlets. The move could also reflect broader sector weakness in advanced materials or industrial technology, or it could stem from a rumor or social media discussion not yet formalized in financial media. Without additional reporting, attribution remains speculative.

UECG

Leverage Shares 2x Long UEC Daily ETF

$5.99−$1.44

-19.4%

NASDAQ

No news headlines were found in the last 48 hours, but UECG is a 2x leveraged ETF tracking uranium stocks, so a sharp 19.43% decline likely reflects a significant drop in the underlying uranium sector or UEC stock itself.

Zero news headlines were provided for the past two days, so there is no direct evidence of a specific catalyst. However, UECG is a leveraged ETF that amplifies daily moves in Uranium Energy Corp (UEC) by a factor of two. A 19.43% loss in UECG would typically correspond to roughly a 9-10% decline in the underlying UEC stock. The most probable causes for such a move in a uranium-sector ETF would be broad uranium market weakness, sector-specific news affecting uranium producers, or a significant adverse development in UEC's operations or outlook. Without access to news, we cannot confirm which category applies, but the leverage structure of this fund means that underlying sector headwinds are magnified significantly.

PLUR

Pluri Inc.Healthcare

$2.52−$0.60

-19.2%

NASDAQ · Mkt cap $17 M

No news headlines were available in the last 48 hours to explain PLUR's 19.23% decline, so the cause remains unclear without additional information about company-specific or market-wide developments.

No news headlines appear in the last 48 hours that would directly explain the sharp 19.23% drop in PLUR stock. Pluri Inc. is a small-cap biotechnology company focused on cell reprogramming and regenerative medicine, sectors that are sensitive to clinical trial results, funding announcements, partnership developments, and regulatory outcomes. Without a headline explaining today's move, the decline could stem from several categories: an unannounced earnings miss or guidance reduction, a clinical setback or trial delay not yet reported in the RSS feed, insider selling or secondary offering, broader biotech sector weakness, or technical/algorithmic selling pressure. The lack of news coverage itself is notable for a 19% mover, suggesting either the catalyst has not yet been publicly disclosed or the move is driven by technical factors rather than fundamentals.

CJMB

Callan JMB Inc. Industrials

$0.79−$0.19

-19.2%

NASDAQ · Mkt cap $15 M

No news headlines were available in the last 48 hours, so the 19.2% decline cannot be directly attributed to a specific announced event. The drop likely stems from technical selling, general market conditions, or undisclosed company developments.

The absence of any news headlines in Yahoo Finance's RSS feed over the last two days makes it difficult to pinpoint a concrete catalyst for CJMB's sharp 19.2% decline. For a micro-cap stock trading at $0.79, price moves of this magnitude can reflect several types of triggers: sustained selling pressure from retail or institutional holders, technical breakdown through a support level, sector-wide weakness affecting the company's industry peers, or potentially undisclosed negative developments that have not yet been widely reported. Penny stocks and very low-priced securities are also prone to greater volatility in response to smaller volume changes and can be sensitive to rumors or social media activity that may not appear in mainstream financial news feeds. Without headline confirmation, we cannot rule out delayed disclosures, insider selling, or operational issues as possibilities.

CISS

C3is Inc.Industrials

$2.57−$0.60

-18.9%

NASDAQ · Mkt cap $4.6 M

C3is reported record earnings growth (358% net income increase, 34% revenue rise) on May 18, yet the stock fell 18.93% the next day, suggesting investors may have viewed the results as already priced in, faced profit-taking, or harbor concerns about forward guidance despite strong Q1 performance.

The earnings announcement on May 18 presents a paradox: C3is delivered exceptional financial results with more than a tripling of net income and solid revenue growth, citing strong tanker market charter rates and improved cash flow. The headlines explicitly praise "record growth" and "improving" market exposure. Yet the stock plummeted nearly 19% the following trading day. This disconnect often occurs when strong results fail to meet elevated expectations, when guidance is cautious despite headline numbers, or when investors use a beat as an exit point after a run-up. The mention of "geopolitical challenges" and "market uncertainties" in the earnings call summary may also have tempered investor confidence about sustainability. Without access to the actual guidance or commentary on forward tanker rates and fleet utilization, we cannot determine if management signaled headwinds ahead. The sell-off appears to reflect either disappointment relative to the bar set, profit-taking, or concern that current market tailwinds may not persist.

PHGE

BiomX Inc.Industrials

$0.37−$0.09

-18.8%

AMEX · Mkt cap $1.5 M

No news headlines were found in the last 48 hours to explain BiomX Inc.'s 18.8% single-day drop, suggesting the move was driven by either a delayed announcement, market technical factors, or undisclosed company developments.

The absence of any recent news coverage is notable given the magnitude of the decline and BiomX's rank as the 26th biggest loser on the day. For a micro-cap biotech stock trading at $0.37, typical catalysts include clinical trial results, regulatory decisions (FDA or similar), partnership announcements, financing developments, or insider actions. The lack of headline coverage could indicate either that the move was technically driven (forced selling, margin calls, or rebalancing), that a material announcement was made through channels not yet picked up by Yahoo Finance RSS, or that negative sentiment accumulated without a single discrete event. BiomX operates in synthetic biology and phage therapy, sectors that can experience sentiment swings based on peer developments or funding environment shifts. Without corroborating news, the specific cause remains speculative.

TDIC

Dreamland Limited Class A Ordinary SharesCommunication Services

$0.58−$0.13

-18.4%

NASDAQ · Mkt cap $4.0 M

No news headlines were found in the last 48 hours, so the 18.44% decline cannot be directly attributed to a specific announced event; the cause remains unclear without additional reporting.

The absence of any recent news in the provided feeds makes it impossible to pinpoint what triggered TDIC's sharp 18.44% drop on this date. For a microcap or thinly traded security like a Class A ordinary share listing, price swings of this magnitude can result from several categories of catalyst: delayed earnings misses or guidance cuts that haven't yet hit major newswires, insider selling or secondary offerings, delisting warnings, short-term technical capitulation, or rumor-driven selling in closed forums before official disclosure. Without access to company filings, regulatory announcements, or real-time trading data beyond what Yahoo Finance captured, we cannot distinguish between these scenarios. The lack of indexed headlines itself may indicate the move was driven by something other than formal corporate news release.

PRPH

ProPhase Labs, Inc.Healthcare

$0.09−$0.02

-18.4%

NASDAQ · Mkt cap $408 K

No headlines were published in the last 48 hours, so the 18.43% drop lacks identifiable news catalyst. The decline likely stems from technical selling, sector weakness, or undisclosed company developments.

ProPhase Labs experienced a significant single-day decline with no recent news coverage to explain it. This presents a gap between the move and publicly available information. For a micro-cap stock trading at $0.09, several common drivers are plausible: technical breakdown below support levels, broader market or healthcare sector weakness, insider activity or rumored developments not yet in headline form, or reaction to stale news that gained traction belatedly. Without access to Level 2 data, institutional flows, or SEC filings from the snapshot date, the specific trigger cannot be determined. Micro-cap stocks are also more susceptible to low-volume capitulation and liquidity-driven moves that may not require external news.

GLOO

Gloo Holdings, Inc.Technology

$5.00−$1.11

-18.2%

NASDAQ · Mkt cap $292 M

No news headlines were found in the last 48 hours, so the 18% drop cannot be attributed to a disclosed event; the decline likely reflects technical selling, market-wide pressure, or an undisclosed catalyst.

The absence of any news in the Yahoo Finance RSS feed over the past two days makes it difficult to pinpoint a specific cause for GLOO's sharp 18% decline. This is noteworthy because a move of this magnitude typically correlates with material events such as earnings misses, guidance cuts, insider selling disclosures, regulatory setbacks, or broader sector rotations. Without access to those details, we can only infer plausible categories: small-cap stocks like GLOO are sensitive to liquidity events and technical breakdown of support levels, which can trigger cascade selling independent of fundamentals. Alternatively, the catalyst could be a delayed announcement or market rumor not yet reflected in major news aggregators, or the stock may have experienced a loss of analyst support or a short-seller report. The timing of the move relative to earnings season, quarterly rebalancing, or index reconstitution should also be considered.

CGTL

Creative Global Technology Holdings Limited Ordinary SharesConsumer Cyclical

$0.39−$0.08

-17.1%

NASDAQ · Mkt cap $8.2 M

CGTL fell 17.08% with no news reported in the last 48 hours, making the specific catalyst unclear; the decline likely stems from technical selling, sector headwinds, or unreported corporate developments.

No headlines were found in the last 48 hours to explain Creative Global Technology Holdings' sharp 17% decline. This absence of reported news makes it difficult to pin down a specific catalyst. For micro-cap technology stocks trading near $0.39, declines of this magnitude without immediate news attribution often fall into a few categories: technical selling pressure from prior resistance levels or broader market weakness in small-cap tech, delayed announcements or guidance misses that have not yet reached major news wires, shareholder dilution or insider selling activity, or shifts in liquidity conditions that disproportionately affect lower-volume equities. Without confirmed reporting on earnings results, management changes, financing activities, or business updates, the root cause remains speculative. The stock's ranking as the 30th biggest loser suggests the move is noteworthy relative to broader market performance that day.

AKAN

Akanda Corp.Healthcare

$13.58−$2.72

-16.7%

NASDAQ · Mkt cap $2.6 M

No news headlines were available in the last 48 hours, so the 16.69% drop likely reflects either a delayed market reaction to an earlier event, technical selling pressure, or sector-wide headwinds affecting cannabis stocks.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for AKAN's sharp decline today. Akanda Corp. operates in the cannabis sector, which is highly sensitive to regulatory developments, earnings misses, guidance cuts, and sector sentiment shifts. The stock could have fallen due to several possible categories of catalyst: a delayed reaction to negative news from more than 48 hours ago, broader weakness in cannabis equities, disappointing quarterly results released outside this news window, management commentary, debt concerns, or simple technical retracement after a prior run. Without access to the specific trigger event, we cannot establish whether this is company-specific or sector-driven, nor can we determine whether the move reflects fundamental deterioration or temporary volatility.

FOXX

Foxx Development Holdings Inc.Technology

$3.85−$0.74

-16.1%

NASDAQ · Mkt cap $20 M

No news headlines were found in the last 48 hours, so the 16% decline cannot be attributed to a specific announced catalyst. The drop likely stems from technical selling, sector rotation, or undisclosed company developments.

Yahoo Finance returned no headlines for FOXX in the past two days, which means we cannot point to a specific earnings miss, guidance cut, regulatory action, or business announcement as the direct cause of the 16.12% decline. For a small-cap development company like Foxx Development Holdings, sharp single-day moves without accompanying news are not unusual and could reflect several factors: profit-taking after a prior run, sector-wide weakness in real estate or construction-related equities, short covering or liquidation, or delayed market reaction to previously released information that did not generate immediate press coverage. Without access to intraday trading data, social media discussion, or company-specific research notes, any specific hypothesis remains speculative.

WALD

Waldencast plcConsumer Defensive

$1.31−$0.25

-16.0%

NASDAQ · Mkt cap $171 M

No news headlines were published in the last 48 hours, so the 16% decline cannot be attributed to a specific disclosed event. The drop likely reflects technical selling, market-wide weakness, or undisclosed company developments.

Waldencast plc experienced a sharp 16% single-day decline with no corresponding news in the Yahoo Finance RSS feed over the prior 48 hours. This disconnect suggests the catalyst was either not yet widely reported, emerged from a non-traditional source, or reflects broader market conditions affecting the stock. Waldencast is a beauty and wellness company; typical catalysts for such steep drops in this sector include missed earnings or guidance cuts, retail inventory problems, loss of a major distribution partner, insider selling announcements, or negative analyst downgrades. Without headline confirmation, we cannot identify which category applies here. The rank as the 33rd biggest loser suggests broader participation rather than isolated weakness, which could indicate sector-wide headwinds or a company-specific disclosure that bypassed major news aggregators temporarily.

BIYA

Baiya International Group Inc. Ordinary SharesTechnology

$0.79−$0.15

-16.0%

NASDAQ · Mkt cap $71 M

No news headlines were found in the last 48 hours, so the 15.96% decline likely stems from technical selling, broader market weakness, or unannounced company developments not yet reported by major outlets.

The absence of any news headlines in Yahoo Finance's last 48 hours means we cannot point to a specific catalyst such as earnings disappointment, regulatory action, guidance cut, or material announcement. For a micro-cap stock trading at $0.79, typical drivers of sharp single-day declines include technical support breaks, short squeeze reversals, options expiry effects, or delayed disclosure of company-specific developments that haven't yet reached major financial news aggregators. It's also possible an announcement was made through less-tracked channels or a negative rumor circulated on retail trading forums. Without evidence-based information, attribution remains speculative.

SNSE

Sensei Biotherapeutics, Inc.Healthcare

$16.77−$3.14

-15.8%

NASDAQ · Mkt cap $44 M

No news headlines were found in the last 48 hours, so the 15.77% decline cannot be attributed to any identifiable public announcement. The drop likely reflects broader biotech sector weakness, clinical trial setbacks, or insider selling, but without reporting it is not possible to determine the s…

Sensei Biotherapeutics is a clinical-stage biotech company with a market cap in the low hundreds of millions, making it sensitive to data events, regulatory decisions, and sentiment shifts in the immunotherapy space. The absence of any news in the last 48 hours means the decline was either driven by intraday technical selling, a delayed market reaction to an older announcement, or an unreported event such as a conference presentation outcome or internal development. For companies of this type and size, common catalysts include trial readouts, partnership news, capital raises, and macroeconomic repricing of biotech risk. Without a specific headline, any explanation remains speculative, though the magnitude of the single-day move suggests an event material enough that news coverage would typically follow within hours.

PETZ

TDH Holdings, Inc.Real Estate

$0.81−$0.15

-15.6%

NASDAQ · Mkt cap $12 M

PETZ dropped 15.63% with no news headlines in the last 48 hours, making the specific catalyst unknown. The move likely reflects sector weakness, technical selling, or unreported developments in the pet services or retail sector.

The absence of any news headlines in the past 48 hours makes it impossible to pinpoint a definite cause for the 15.63% single-day decline. TDH Holdings operates in the pet retail and services space, which can be sensitive to consumer spending trends, supply chain disruptions, or shifts in investor sentiment toward that sector. Without reported earnings surprises, guidance changes, competitive announcements, or management developments, we must consider either technical factors such as short covering reversals or profit-taking after a prior rally, broader sector headwinds affecting pet retailers and services companies, or unreported company-specific news that has not yet surfaced on major financial RSS feeds. The stock's low price of $0.81 also suggests it may be a penny or microcap with lower coverage and less reliable information flow, which increases the likelihood that meaningful developments occur without immediate press pickup.

TGEN

Tecogen Inc.Industrials

$5.36−$0.99

-15.6%

AMEX · Mkt cap $110 M

No news headlines were found in the last 48 hours, so the 15.59% decline cannot be directly attributed to a reported event. The drop likely stems from sector weakness, technical selling, or unannounced company developments.

Tecogen is a small-cap energy and microgrid technology company, and the absence of recent news headlines makes it difficult to pinpoint a specific catalyst for today's sharp 15.59% decline. Small-cap stocks on exchanges like AMEX are often sensitive to technical factors, including momentum reversals, institutional rebalancing, or broad energy sector headwinds. Possible explanations include negative sector sentiment affecting distributed energy or CHP (combined heat and power) markets, profit-taking after a prior run-up, insider news not yet public, or deteriorating technical support. Without substantive new information, any explanation remains speculative.

AGMH

AGM Group Holdings Inc.Technology

$1.03−$0.19

-15.6%

EZRA

Reliance Global Group Inc.Financial Services

$3.86−$0.70

-15.4%

NASDAQ · Mkt cap $2.0 M

EZRA dropped 15.35% despite announcing Israel Innovation Authority approval for a 5G deployment project, suggesting the market either did not view the news as material or there was negative sentiment unrelated to this announcement.

The single headline provided reports a positive development: Israel Innovation Authority approval for Reliance Global Group's Enquantum Private 5G deployment and Smart Infrastructure initiatives under the Scale51 program. This is framed as a milestone following a successful pilot. However, the stock fell sharply on the same day the news was released. This disconnect suggests either the market perceived the approval as already priced in, viewed the commercialization timeline or revenue potential as underwhelming, or that a separate negative catalyst not captured in these headlines drove the decline. For a small-cap technology company like EZRA, intraday momentum reversals, short covering, or broader market selling in the NASDAQ tech space are also plausible explanations. Without access to trading volume, analyst commentary, or competing news, the precise cause remains unclear.

FCUV

Focus Universal Inc.Technology

$0.73−$0.13

-15.3%

NASDAQ · Mkt cap $5.7 M

No news headlines were published in the last 48 hours, so the 15.3% drop cannot be tied to a specific announcement or event. The decline likely stems from technical selling, sector rotation, or unannounced company developments.

The absence of any recent news headlines in the Yahoo Finance RSS feed means we cannot point to a concrete catalyst such as earnings, guidance change, regulatory action, or corporate announcement. Focus Universal is a micro-cap stock trading at $0.73, which typically exhibits higher volatility and lower liquidity than larger companies. Such stocks are susceptible to sharp intraday moves driven by technical factors, momentum shifts, short-covering, or sector-wide pressure. Without headlines to anchor our analysis, we cannot determine whether the decline reflects fundamental deterioration or temporary trading dynamics. The company may have released information through channels not captured in this feed, or the move may be purely technical in nature.

PDSB

PDS Biotechnology CorporationHealthcare

$1.00−$0.18

-15.3%

NASDAQ · Mkt cap $11 M

No news headlines were published in the last 48 hours, so the 15.25% drop cannot be attributed to a specific announced event. The decline likely reflects sector weakness, technical selling, or undisclosed developments.

PDS Biotechnology is a small-cap biotech firm, and the absence of recent headlines means no earnings surprise, FDA decision, clinical trial result, or strategic announcement can be identified as the direct cause. Biotech stocks of this size are often volatile and sensitive to broad sector sentiment, short-covering, or liquidity events that may not generate immediate news coverage. The drop could also reflect delayed market reaction to an earlier announcement, internal developments not yet public, or technical selling pressure. Without corroborating news, the root cause remains unclear, though sector rotation away from smaller biologics or a negative update from a prior event are plausible categories.

PBM

Psyence Biomedical Ltd.Healthcare

$3.91−$0.70

-15.2%

NASDAQ · Mkt cap $16 M

No headlines were found in the last 48 hours, so the cause of the 15.18% drop cannot be determined from news; the decline may reflect broader biomedical sector weakness, clinical trial setbacks, or other undisclosed developments.

Yahoo Finance returned no headlines for PBM in the last 48 hours, making it impossible to attribute the significant 15.18% decline to any announced event such as earnings, FDA action, trial results, or guidance revision. Psyence Biomedical is a biomedical company, and stocks in this space are sensitive to clinical development milestones, regulatory decisions, and capital raises. Without news coverage, the move could reflect a delayed market reaction to an earlier announcement, sector-wide selling pressure, an internal development not yet widely reported, or technical factors. The gap between a notable intraday loss and the absence of corresponding headlines suggests either that the catalyst has not yet been publicly disclosed, or that the market is responding to information not captured in the RSS feed used here.

KMRK

K-Tech Solutions Company LimitedConsumer Cyclical

$2.13−$0.38

-15.1%

NASDAQ · Mkt cap $24 M

No news headlines were found in the last 48 hours for KMRK, so the 15% drop likely reflects either a delayed market reaction to an untracked announcement, technical selling pressure, or broad sector weakness not captured in the provided data.

The absence of any Yahoo Finance RSS headlines in the last 48 hours makes it impossible to pinpoint a specific catalyst for the 15.14% decline. For a micro-cap or thinly traded stock like KMRK trading at $2.13, price swings of this magnitude can occur from several sources: unexpected earnings misses or guidance cuts announced outside typical news channels, insider selling or lock-up expirations, sector-wide declines in technology stocks, or technical breakdown through a support level triggering stop-loss orders. Without access to press releases, earnings calendars, or SEC filings released within this window, any explanation remains speculative. The stock's ranking as the 43rd biggest loser suggests the move was material but not extraordinary relative to the broader market, which might indicate company-specific rather than market-wide factors.

GEMG

Leverage Shares 2x Long GEMI Daily ETF

$13.05−$2.33

-15.1%

NASDAQ

No news headlines were found in the last 48 hours, so the 15.13% drop was likely driven by a decline in the underlying GEMI index or broad market weakness on the day, amplified by the 2x leverage structure of this ETF.

GEMG is a 2x leveraged long daily ETF tracking GEMI, which means it amplifies both gains and losses of its underlying index by a factor of two. With no news reported in the past 48 hours, the decline is most likely mechanical: either GEMI itself fell approximately 7.6% on May 19, or the broader market environment deteriorated, causing GEMI to decline and GEMG to amplify that loss. Leveraged ETFs also experience daily rebalancing decay, especially in volatile markets, which can contribute to underperformance. Without headline-level catalysts, the move reflects normal market dynamics affecting the underlying index, magnified by the fund's structural leverage.

OXSQ

Oxford Square Capital Corp.Financial Services

$1.30−$0.23

-15.0%

NASDAQ · Mkt cap $153 M

No news headlines were published in the last 48 hours for OXSQ, so the 15% drop cannot be attributed to a specific announced event. The decline likely reflects sector-wide pressure, dividend or distribution concerns, or technical selling in the closed-end fund space.

Oxford Square Capital Corp. is a closed-end management company (BDC) that invests in middle-market companies, and its share price is sensitive to net asset value changes, interest rate movements, and market sentiment toward credit risk. Without any news headlines in the past 48 hours, we cannot point to an earnings miss, portfolio announcement, or management action as the direct cause. However, BDCs typically react sharply to (1) rising interest rates, which compress valuations and increase borrowing costs, (2) concerns about credit quality or default risks in their portfolios, or (3) dividend coverage worries. A 15% single-day move in a lower-priced BDC can also reflect tax-loss selling, technical breakdown, or broader credit market stress. The absence of news does not rule out a delayed market reaction to a prior announcement or a data-driven reassessment by investors.

NXTS

N2OFF, Inc.Basic Materials

$4.20−$0.74

-15.0%

NASDAQ · Mkt cap $117 K

Nexentis announced a positive R&D milestone on May 18, but the stock fell 15% the next day anyway, suggesting the market either viewed the milestone as underwhelming, sold on the news despite the positive headline, or reacted to unrelated market or company-specific factors.

The company announced that its MitoCareX Bio subsidiary achieved a key R&D milestone with an improved hit molecule moving toward pre-clinical development. This is ostensibly positive news for a drug discovery company. However, the stock declined significantly the following day, which contradicts a typical positive reaction. This discrepancy could reflect several scenarios: the market may have had higher expectations than what the milestone represented, investors may have sold into the news despite the positive framing, or the decline may be driven by entirely separate factors such as broader sector weakness, insider selling, a delayed negative announcement, or technical retracement after a prior rally. Without additional context on the stock's recent price history, sector performance on May 19, or management guidance, it is impossible to determine which driver was primary.

JXG

JX Luxventure LimitedConsumer Cyclical

$5.57−$0.96

-14.7%

NASDAQ · Mkt cap $94 M

JXG dropped 14.70% on May 19 with no reported news in the last 48 hours, making the specific catalyst unclear and suggesting the move may reflect technical selling, market-wide volatility, or unreported company-specific developments.

The absence of any headlines in the past 48 hours means we cannot point to a named event such as earnings, guidance, regulatory action, or corporate news to explain this 14.70% decline. JX Luxventure Limited is a small-cap equity, and stocks in this category are often subject to larger percentage swings on thin liquidity, technical selling, or delayed reporting of news events that may not yet have reached major financial wire services. The stock ranks 47th among daily losers, suggesting broad participation in the decline rather than isolated selling. Without access to press releases, SEC filings, social media, or company investor relations channels, we cannot rule out that material news exists but simply has not yet propagated through the Yahoo Finance RSS feed.

ALTG

Alta Equipment Group Inc.Industrials

$5.54−$0.95

-14.6%

NYSE · Mkt cap $237 M

ALTG dropped 14.64% with no news reported in the last 48 hours, so the cause remains unclear; the move may reflect broader market weakness, technical selling, or an untracked announcement.

No headlines were found in the last 48 hours to explain Alta Equipment Group's sharp 14.64% decline. Without news-driven catalysts, the move likely stems from one of several generic causes: sector-wide pressure affecting equipment distributors or rental companies, technical selling following a technical level breach, profit-taking after a run-up, or deterioration in company-specific fundamentals or guidance that has not yet been picked up by major news feeds. Equipment rental and distribution stocks are cyclical and can be sensitive to macroeconomic expectations, interest rates, and customer demand signals. It is also possible that material information was announced through a channel not captured by Yahoo Finance RSS, such as a press release issued outside normal news cycles or late-day trading volatility driven by institutional positioning.

BOT

RoboStrategy, Inc. Common StockFinancial Services

$24.21−$4.15

-14.6%

NASDAQ · Mkt cap $665 M

BOT dropped 14.63% on no material news in the past 48 hours; the single headline was a generic industry tailwind article published before market open, suggesting the decline was driven by sector rotation, profit-taking, or an undisclosed catalyst.

The provided headline from May 18 is a positive industry feature noting that robotics stocks are emerging opportunities as physical AI gains momentum. This is bullish framing and was published before the sharp decline, making it an unlikely cause of the sell-off. The magnitude of the drop (nearly 15% in a single day) typically reflects either a significant company-specific event not captured in the headlines provided, broader sector weakness unrelated to the positive robotics narrative, or a delayed market reaction to news published earlier. For a stock in the robotics and AI space, common catalysts for sharp declines include earnings misses, guidance reductions, loss of a major contract, executive departures, or macro-driven flight from high-growth equities. Without access to intraday news or detailed company announcements, the specific trigger remains unclear.

UUUG

Leverage Shares 2x Long UUUU Daily ETF

$7.22−$1.23

-14.6%

NASDAQ

No news headlines appeared in the last 48 hours, but UUUG is a 2x leveraged long ETF that amplifies daily moves in its underlying asset UUUU, so a roughly 7% decline in the underlying would produce this 14% drop mechanically.

There are no recent news headlines available to explain the move directly. However, UUUG's structure is critical context: as a 2x daily leveraged long ETF tracking UUUU, it is designed to amplify both gains and losses in the underlying security by a factor of approximately two on a daily basis. A 14.56% decline in UUUG is therefore consistent with an approximately 7% decline in UUUU itself. Without headlines, the cause of UUUU's drop is unknown, but leveraged ETFs are sensitive to daily price action in their underlying assets and require no external news catalyst—simple downward pressure on UUUU would mechanically produce this result. The missing piece is why UUUU itself fell, which could range from sector rotation to company-specific developments to technical selling.